This is an archive page. The links are no longer being updated.

Date:  Wednesday, November 13, 1996
FOR IMMEDIATE RELEASE
CONTACTS:  NHLBI Communications Office, (301) 496-4236, Vicky
Cahan, NIA Information Office, (301) 496-1752

Sodium Reduction/Weight Loss Cut Need for Drugs in Elderly

Studies Show Lifestyle Changes Benefit Blood Pressure



Findings from two National Institutes of Health (NIH)-supported studies show that lifestyle changes, such as modifying one's diet and losing weight, substantially reduce blood pressure in adults and can keep older patients off antihypertensive medication. Findings from the studies are being presented at the American Heart Association scientific sessions in New Orleans, LA.

The "Dietary Approaches to Stop Hypertension" (DASH) Trial was funded by the National Heart, Lung, and Blood Institute (NHLBI) and the National Center for Research Resources, with supplemental support from the NIH Office of Research on Minority Health. The "Trial of Nonpharmacologic Interventions in the Elderly" (TONE) was funded by the National Institute on Aging (NIA), with additional support from the NHLBI.

Dr. Thomas Moore of Brigham and Women's Hospital in Boston, MA, will speak about DASH at the late-breaking clinical trials session at 2:15 p.m. on November 13. Dr. Paul Whelton, director of the Welch Center for Prevention, Epidemiology, and Clinical Research at The Johns Hopkins University School of Hygiene and Public Health and School of Medicine in Baltimore, MD, will present TONE's main results at 4:30 p.m. on November 11. Dr. Shiriki Kumanyika of the University of Illinois at Chicago, will describe the TONE intervention 2:00 p.m. on November 13.

"With 50 million Americans having hypertension and many developing it each year, the findings of these two studies have very important public health implications," said NHLBI Director Dr. Claude Lenfant. "The results show the value of lifestyle changes in preventing and controlling this condition," he added.

The studies' results are:

"This study provides important news for older Americans, many of whom may be able to reduce their use of antihypertensive medication if they make certain lifestyle changes," said

Dr. Richard J. Hodes, director of the NIA. "Patients who are now taking medications for high blood pressure should not discontinue or alter their medications without consulting their physician," Dr. Hodes stressed.

The multicenter, 3-year study involved 975 patients at four medical centers--Johns Hopkins University School of Hygiene and Public Health and School of Medicine in Baltimore, MD, the University of Tennessee in Memphis, the University of Medicine and Dentistry of New Jersey--Robert Wood Johnson School of Medicine in New Brunswick, and the Bowman Gray School of Medicine in Winston-Salem, NC.

The study tested the effects on blood pressure of weight loss and sodium reduction, alone and in combination, in non-overweight and overweight patients, ages 60 to 80, whose blood pressure was being controlled by one medication. Patients were men and women; about a quarter were African American.

The 585 overweight patients were assigned to one of four treatments: weight loss alone, sodium reduction alone, combined weight loss and sodium reduction, or usual care, which involved no lifestyle change. The 390 non-overweight patients were assigned to either the sodium reduction or usual care.

At the outset, patients were taking a single antihypertensive medication to keep their blood pressures below 150/90 mm Hg. About 3 months after patients were assigned to a treatment, an attempt was made to taper and discontinue their antihypertensive medication under close supervision. The antihypertensive medication was restarted if a patient's blood pressure did not stay below 150/90 or a physician determined it was needed.

Patients in the weight reduction groups lost 10 to 12 pounds on average. Average sodium intake was reduced to about 2300 mg a day for non-overweight patients and to about 2900 mg for those who were overweight. These reductions were well maintained during followup. The results showed that sodium reduction and weight loss each decreased patients' need for treatment with antihypertensive medication by about 40 percent. After 30 months of followup, almost 40 percent of the patients assigned to the treatments had their blood pressures under control without an antihypertensive medication. Patients assigned to the combination of sodium reduction and weight loss therapy did especially well at maintaining control of their blood pressures without an antihypertensive medication.

To monitor treatment safety, the study looked at patients' cardiovascular events, such as stroke, heart attack, and angina. Few such events occurred in the groups and there were no significant differences among the therapies.

Dr. Eva Obarzanek, nutritionist, and Dr. Jeffrey Cutler, director of the Clinical Applications and Prevention Program, are the NHLBI project officers for DASH and TONE, respectively. To arrange an interview with them, call the NHLBI Communications Office.

Dr. Andre Premen, director of NIA's Cardiovascular Aging Program, is the NIA Project Officer for TONE. To arrange an interview with him or for more information on hypertension and the elderly, call the NIA Information Office.